Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer-Reference-Cited by-同舟云学术

Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer

Author:

Garris Christopher S.¹^ORCID,Wong Jeffrey L.¹²^ORCID,Ravetch Jeffrey V.¹^ORCID,Knorr David A.¹²^ORCID

Affiliation:

1. Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065, USA.

2. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Abstract

Fc-optimized CD40 agonist antibodies drive local and systemic immunity against bladder cancer in mice.

Funder

National Cancer Institute

V Foundation for Cancer Research

American Society of Hematology

National Center for Advancing Translational Sciences

American Society of Clinical Oncology

Bladder Cancer Advocacy Network

Robertson Therapeutic Development Fund

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference58 articles.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献